Early B Cell Factor 1 Regulates B Cell Gene Networks by Activation, Repression, and Transcription-Independent Poising of Chromatin

被引:173
作者
Treiber, Thomas [1 ]
Mandel, Elizabeth M. [1 ]
Pott, Sebastian [2 ]
Gyoery, Ildiko [1 ]
Firner, Sonja [1 ]
Liu, Edison T. [2 ]
Grosschedl, Rudolf [1 ]
机构
[1] Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany
[2] Genome Inst Singapore, Singapore 138672, Singapore
关键词
FATE COMMITMENT; FACTOR EBF; EXPRESSION; SPECIFICATION; INTERLEUKIN-7; DIFFERENTIATION; PAX5; E2A; LYMPHOPOIESIS; INDUCTION;
D O I
10.1016/j.immuni.2010.04.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The transcription factor early B cell factor-1 (Ebf1) is a key determinant of B lineage specification and differentiation. To gain insight into the molecular basis of Ebf1 function in early-stage B cells, we combined a genome-wide ChIP sequencing analysis with gain- and loss-of-function transcriptome analyses. Among 565 genes that are occupied and transcriptionally regulated by Ebf1, we identified large sets involved in (pre)-B cell receptor and Akt signaling, cell adhesion, and migration. Interestingly, a third of previously described Pax5 targets was found to be occupied by Ebf1. In addition to Ebf1-activated and -repressed genes, we identified targets at which Ebf1 induces chromatin changes that poise the genes for expression at subsequent stages of differentiation. Poised chromatin states on specific targets could also be established by Ebf1 expression in T cells but not in NI H 3T3 cells, suggesting that Ebf1 acts as a "pioneer" factor in a hematopoietic chromatin context.
引用
收藏
页码:714 / 725
页数:12
相关论文
共 57 条
[1]   BANK negatively regulates Akt activation and subsequent B cell responses [J].
Aiba, Y ;
Yamazaki, T ;
Okada, T ;
Gotoh, K ;
Sanjo, H ;
Ogata, M ;
Kurosaki, T .
IMMUNITY, 2006, 24 (03) :259-268
[2]   E2A PROTEINS ARE REQUIRED FOR PROPER B-CELL DEVELOPMENT AND INITIATION OF IMMUNOGLOBULIN GENE REARRANGEMENTS [J].
BAIN, G ;
MAANDAG, ECR ;
IZON, DJ ;
AMSEN, D ;
KRUISBEEK, AM ;
WEINTRAUB, BC ;
KROP, I ;
SCHLISSEL, MS ;
FEENEY, AJ ;
VANROON, M ;
VANDERVALK, M ;
TERIELE, HPJ ;
BERNS, A ;
MURRE, C .
CELL, 1994, 79 (05) :885-892
[3]   A bivalent chromatin structure marks key developmental genes in embryonic stem cells [J].
Bernstein, BE ;
Mikkelsen, TS ;
Xie, XH ;
Kamal, M ;
Huebert, DJ ;
Cuff, J ;
Fry, B ;
Meissner, A ;
Wernig, M ;
Plath, K ;
Jaenisch, R ;
Wagschal, A ;
Feil, R ;
Schreiber, SL ;
Lander, ES .
CELL, 2006, 125 (02) :315-326
[4]  
Brezski RJ, 2008, ADV EXP MED BIOL, V640, P12, DOI 10.1007/978-0-387-09789-3_2
[5]   Transcriptional control of early B cell development [J].
Busslinger, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :55-79
[6]   Integration of external signaling pathways with the core transcriptional network in embryonic stem cells [J].
Chen, Xi ;
Xu, Han ;
Yuan, Ping ;
Fang, Fang ;
Huss, Mikael ;
Vega, Vinsensius B. ;
Wong, Eleanor ;
Orlov, Yuriy L. ;
Zhang, Weiwei ;
Jiang, Jianming ;
Loh, Yuin-Han ;
Yeo, Hock Chuan ;
Yeo, Zhen Xuan ;
Narang, Vipin ;
Govindarajan, Kunde Ramamoorthy ;
Leong, Bernard ;
Shahab, Atif ;
Ruan, Yijun ;
Bourque, Guillaume ;
Sung, Wing-Kin ;
Clarke, Neil D. ;
Wei, Chia-Lin ;
Ng, Huck-Hui .
CELL, 2008, 133 (06) :1106-1117
[7]   Genomic Analyses of Hormone Signaling and Gene Regulation [J].
Cheung, Edwin ;
Kraus, W. Lee .
ANNUAL REVIEW OF PHYSIOLOGY, 2010, 72 :191-218
[8]   Stepwise Activation of Enhancer and Promoter Regions of the B Cell Commitment Gene Pax5 in Early Lymphopoiesis [J].
Decker, Thorsten ;
di Magliano, Marina Pasca ;
McManus, Shane ;
Sun, Qiong ;
Bonifer, Constanze ;
Tagoh, Hiromi ;
Busslinger, Meinrad .
IMMUNITY, 2009, 30 (04) :508-520
[9]   PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors [J].
DeKoter, RP ;
Lee, HJ ;
Singh, H .
IMMUNITY, 2002, 16 (02) :297-309
[10]   Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells [J].
Delogu, A ;
Schebesta, A ;
Sun, Q ;
Aschenbrenner, K ;
Perlot, T ;
Busslinger, M .
IMMUNITY, 2006, 24 (03) :269-281